ATE550339T1 - Kristallines clopidogrelnaphthalinsulfonat oder hydrat davon, verfahren zu dessen herstellung und pharmazeutische zusammensetzung, die dieses enthält - Google Patents

Kristallines clopidogrelnaphthalinsulfonat oder hydrat davon, verfahren zu dessen herstellung und pharmazeutische zusammensetzung, die dieses enthält

Info

Publication number
ATE550339T1
ATE550339T1 AT04793523T AT04793523T ATE550339T1 AT E550339 T1 ATE550339 T1 AT E550339T1 AT 04793523 T AT04793523 T AT 04793523T AT 04793523 T AT04793523 T AT 04793523T AT E550339 T1 ATE550339 T1 AT E550339T1
Authority
AT
Austria
Prior art keywords
napthhaline
sulphonate
hydrate
production
pharmaceutical composition
Prior art date
Application number
AT04793523T
Other languages
English (en)
Inventor
Sangmin Yun
Eun Sook Kim
Hee Seock Kim
Bo Sung Kwon
Cheol Kyung Jugong -Cha Apt Kim
Han Kyong Kim
Kwee-Hyun Suh
Gwan Sun Lee
Original Assignee
Hanmi Holdings Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hanmi Holdings Co Ltd filed Critical Hanmi Holdings Co Ltd
Priority claimed from PCT/KR2004/002665 external-priority patent/WO2005097804A1/en
Application granted granted Critical
Publication of ATE550339T1 publication Critical patent/ATE550339T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system having sulfur as a ring hetero atom, e.g. ticlopidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT04793523T 2004-04-09 2004-10-18 Kristallines clopidogrelnaphthalinsulfonat oder hydrat davon, verfahren zu dessen herstellung und pharmazeutische zusammensetzung, die dieses enthält ATE550339T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR20040024361 2004-04-09
KR1020040041309A KR100563455B1 (ko) 2004-04-09 2004-06-07 결정성 클로피도그렐 나프탈렌술폰산염 또는 이의 수화물,이의 제조방법 및 이를 함유하는 약학적 조성물
PCT/KR2004/002665 WO2005097804A1 (en) 2004-04-09 2004-10-18 Crystalline clopidogrel naphthalenesulfonate or hydrate thereof, method for preparing same and pharmaceutical composition containing same

Publications (1)

Publication Number Publication Date
ATE550339T1 true ATE550339T1 (de) 2012-04-15

Family

ID=37278598

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04793523T ATE550339T1 (de) 2004-04-09 2004-10-18 Kristallines clopidogrelnaphthalinsulfonat oder hydrat davon, verfahren zu dessen herstellung und pharmazeutische zusammensetzung, die dieses enthält

Country Status (3)

Country Link
KR (1) KR100563455B1 (de)
AT (1) ATE550339T1 (de)
ZA (1) ZA200609248B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100945062B1 (ko) * 2006-03-22 2010-03-05 한미약품 주식회사 클로피도그렐 1,5-나프탈렌디술폰산염 및 이의 수화물의제조방법
KR100988233B1 (ko) * 2007-12-26 2010-10-18 한미홀딩스 주식회사 클로피도그렐 1,5-나프탈렌 다이술폰산 염 또는 이의수화물의 약학 조성물 및 제제

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2623810B2 (fr) * 1987-02-17 1992-01-24 Sanofi Sa Sels de l'alpha-(tetrahydro-4,5,6,7 thieno(3,2-c) pyridyl-5) (chloro-2 phenyl) -acetate de methyle dextrogyre et compositions pharmaceutiques en contenant
FR2751540B1 (fr) * 1996-07-26 1998-10-16 Sanofi Sa Composition pharmaceutique antithrombotique
IN191030B (de) * 2001-01-24 2003-09-13 Cadila Healthcare Ltd
DE10305984A1 (de) * 2003-02-13 2004-09-02 Helm Ag Salze organischer Säuren mit Clopidogrel und deren Verwendung zur Herstellung phamazeutischer Formulierungen

Also Published As

Publication number Publication date
ZA200609248B (en) 2008-05-28
KR100563455B1 (ko) 2006-03-23
KR20050099445A (ko) 2005-10-13

Similar Documents

Publication Publication Date Title
ATE452883T1 (de) KRISTALLINE FORM VON 1-CHLOR-4-(ß-D-GLUCOPYRANOS- 1-YL)-2-Ä4-((S)-TETRAHYDROFURAN-3-YLOXY)- BENZYLÜBENZOL, VERFAHREN ZU DESSEN HERSTELLUNG UND DESSEN VERWENDUNG ZUR HERSTELLUNG VON MEDIKAMENTEN
IL177087A0 (en) Controlled-release pharmaceutical composition and method for producing the same
DE60305105D1 (de) Aluminiumbeschichtetes Bauteil und Verfahren zu dessen Herstellung
IL198718A0 (en) Novel 1,4-benzothiepin-1,1-dioxide derivatives which are substituted with benzyl groups, method for producing drugs containing said compounds and use thereof
DE502004011328D1 (de) Substituierte hexahydro-pyrazino(1,2-a)pyrimidin-4,7-dionderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
ATE556077T1 (de) Tetrahydrochinolinderivate und verfahren zu deren herstellung
PL1877409T3 (pl) Nowe podstawione pirolopirydyny, kompozycja je zawierająca, sposób ich wytwarzania oraz ich zastosowanie
ATE471930T1 (de) 3-aminocarbazolverbindungen, pharmazeutische zusammensetzungen, die diese enthalten, und verfahren zu deren herstellung
DE50310782D1 (de) Piezoaktor und verfahren zu dessen herstellung
DK1440936T3 (da) Krystalliseret IM-9-faststof samt fremgangsmåde til fremstilling deraf
HK1098482A1 (en) Crystalline clopidogrel naphthalenesulfonate or hydrate thereof, method for preparing same and pharmaceutical composition containing same
ATE482193T1 (de) Indolonacetamidderivate, verfahren zu deren herstellung und deren verwendungen
DE602004008991D1 (de) Umlenkbeschlag und verfahren zu dessen herstellung
DE602004006177D1 (de) Wildlederartiges Kunstleder und Verfahren zu dessen Herstellung
IL178887A0 (en) Novel beta agonists, method for producing the same and their use as drugs
DE50307428D1 (de) Sitzeinlage und verfahren zu ihrer herstellung
ATE337317T1 (de) Imidazopyrin-derivate, verfahren zu ihrer herstellung and sie enthaltende pharmazeutische zusamensetzungen
ATE381338T1 (de) Benzothiadiazinderivate, verfahren zu deren herstellung und pharmazeutische zusammensetzungen,die diese enthalten
DE602004002231D1 (de) Knochenkontaktierendes Implantat mit stossdämpfenden Eigenschaften und Verfahren zu dessen Herstellung
DE60315262D1 (de) Pvb folie mit geringer verfärbung und verfahren zu ihrer herstellung
DE602005003678D1 (de) Gemischtes olanzapinsolvat, verfahren zu dessen herstellung und verfahren zur herstellung von olanzapin-form i daraus
DE60321751D1 (de) Polyurethan-Harnstoffe, nützlich zur Herstellung von Spandex und ein Verfahren zu ihrer Herstellung
DE60323689D1 (de) Schräg geschichtetes furniermaterial und verfahren zu dessen herstellung
DE602004031350D1 (de) Penamkristall und verfahren zu dessen herstellung
ATE388936T1 (de) 9-chloro-15-deoxyprostaglandinderivate, verfahren zu ihrer herstellung und deren verwendung als medikamente